Ypsomed expands to North America

Press Releases Ypsomed Group

Burgdorf – Ypsomed establishes its first subsidiary in North America, Canada. The foundation in Canada is another important milestone in the consistently pursued growth strategy. At the same time, the mylife™ YpsoPump® insulin pump is launched in India.

Swisscom and Ypsomed test 5G in production operations for the first time

Press Releases Ypsomed Group

Burgdorf - Swisscom and Ypsomed have been cooperating since the spring of 2017 to develop application options for the latest generation of mobile communications. Ypsomed has digitised selected production processes with 5G. This simplifies processes considerably, makes them even safer and more efficient.

Ypsomed is driving the digitisation of its portfolio

Press Releases Ypsomed Group

Burgdorf – Ypsomed continues to expand its offers for digital diabetes therapy with the launch of the mylife™ App. The mylife™ App is connected to the mylife™ YpsoPump® insulin pump via Bluetooth® and continuously records current therapy data. Digital therapy solutions add to customer benefit and increase the success of therapy long-term.

Press Releases Ypsomed Group

Burgdorf – Ypsomed and the US Bigfoot Biomedical company today announced their agreement for a partnership. Ypsomed will supply Bigfoot Biomedical with a modified, patented version of the Orbit infusion set. This will be used by Bigfoot in their clinical study on automated insulin therapy in people with diabetes.

Press Releases Ypsomed Group

Burgdorf – Following the successful launch of its own insulin pump, the mylife YpsoPump, Ypsomed pursues its continued growth and invests in establishing new subsidiaries throughout Europe. At the same time, the mylife YpsoPump is being launched in further European countries.